Search for stocks /

Muthoot Microfin Ltd Q1 FY26 – Microfinance ki IPL Team: Har Saal Semi-Final Tak, Final Kab Aayega?


1. At a Glance

Muthoot Microfin is like that cousin who topped school exams but keeps failing the driving test. India’s 2nd largest NBFC-MFI, 1,593 branches, ₹12,519 crore loan book, and an app with 1.7 million downloads. Yet, FY25 ended with a ₹222 crore net loss. The company lends small amounts to rural women and then collects big amounts of bad press whenever NPAs rise.


2. Introduction

If India had a Netflix series on microfinance, Muthoot Microfin would be the main lead. The pitch is strong: empowering rural women with livelihood loans, solar lamps, sanitary facilities, and even e-clinics. The reality check: debt pile of ₹8,100 crore, GNPA swinging like Virat Kohli’s bat – 2.7% in H1FY25 but a scary 4.84% in FY25 results.

The IPO in Dec 2023 raised ₹960 crore. But within 18 months, stock price slipped from ₹240 peak to ₹166. Basically, investors got Pragathi Loan ka version – paisa aaya, but progress ka waitlist abhi bhi chalu hai.

Question for readers: do you think MFIs can actually make money in India without turning into loan sharks, or is this sector permanently in “CSR with interest rates” mode?


3. Business Model – WTF Do They Even Do?

Muthoot Microfin follows the joint liability group (JLG) model – gather women in a group, lend small ticket loans (₹30,000–₹50,000), then recover through weekly or monthly collections.

Loan Categories:

  • Livelihood loans – 96.7% of portfolio (think tailoring machines, kirana stocking, goats, micro-businesses).
  • Pragathi loans – bridging working capital gaps.
  • Life betterment loans – mobile phones, solar lamps.
  • Health & hygiene loans – toilets, water filters.
  • Gold loans – because Muthoot without gold is like Rajnikanth without sunglasses.
  • MSGB (Small & Growing Business loans) – basically SME ka trial version.

Digital push is through their “Mahila Mitra” app – QR collections, SMS pay links. ₹569 crore collected digitally in Q2 FY25, a solid 24% of total. E-clinics are their new CSR+fintech experiment: 460 branches with telemedicine, because why not add healthcare when banking already gives you BP?


4. Financials Overview

MetricLatest Qtr (Jun’25)YoY Qtr (Jun’24)Prev Qtr (Mar’25)YoY %QoQ %
Revenue₹559 Cr₹663 Cr₹555 Cr-15.8%0.7%
EBITDA₹226 Cr₹390 Cr-₹290 Cr-42.0%Turnaround
PAT₹6.2 Cr₹113 Cr-₹401 Cr-94.5%Swing from loss
EPS (₹)0.366.64-23.53-94.5%N/A

Commentary: This looks like a batsman who hit a century last year, got a duck last match, and somehow managed a lucky single this time. EPS annualized is ₹1.44 – P/E is not meaningful because last year EPS was negative.


5. Valuation Discussion – Fair Value Range Only

  • P/E Method: Sector median P/E ~58. With EPS of ₹1.44 (annualized), implied fair range = ₹84 – ₹116.
  • EV/EBITDA: EV ₹9,765 Cr / FY25 EBITDA ₹682 Cr → 14.3x. Sector MFIs usually trade at 12–20x → range ₹140 – ₹180.
  • DCF (back-of-envelope): Assume 15% loan growth, 3% ROA target, discount at 12%. FCFE-based DCF suggests range ₹150 – ₹200.

🎯 Fair Value Range: ₹84 – ₹200 (wide enough to drive a tractor through).
Disclaimer: This fair value range is for educational purposes only and is not investment advice.


6. What’s Cooking – News, Triggers, Drama

  • FY25 Results: Loss of ₹222 Cr, 9.4% credit cost, AUM growth just 1.3%.
  • Bond/NCD Issuances: Sep 2025 board approved USD 15M bonds + ₹150 Cr NCDs. Basically, refill petrol in a leaky scooter.
  • ESG Rating: Top-tier ESG rating despite losses – because “saving goats” scores higher than “saving profits.”
  • Job Fair: Created 1500 jobs in Sep 2024. Investor job still open: “Patience Required, Salary = Zero.”
  • Rate Cuts: Reduced lending rates thrice in
error: Content is protected !!